Why is there such a dearth of companies listing on the NZX?
It has been months since the last listing on the NZ Stock Exchange.
AdvertisementAdvertise with NZME.
Latest from Stock takes
How this NZ pharma firm prices drugs to avoid villain status
This NZ drug maker says it puts health above wealth.
No easy fix for high inflation environment
Fisher Funds portfolio manager Matt Peek talks about the impact of the Budget.
A capital raise for Synlait - or something more radical for balance sheet woes?
Stock Takes: Is the underperforming Synlait Milk heading toward another capital raise?
‘A rounding error’: Why Govt’s $4b Budget boost doesn’t signal big spend-up
The no-frills Budget needs to focus on the basics.
Is it time to list Ports of Auckland on share market?
A new report has highlighted some problems with local government ownership.
Cost of Gabrielle and January floods will run into billions of dollars
Infometrics CEO Brad Olsen talks floods and reporting season.
Why the Aussie share market is looking more attractive
And Fletcher Building gets an earning's downgrade from one analyst.
Continuous Disclosure: IPO drought over and Rod Duke's latest purchase
What is happening on the markets this week.
Stock take: Death of the cinema? Plus the surprise in store for Fletcher shareholders
What's happening on the markets this week.
Continuous Disclosure: High demand for Auckland Council bond and IPO warning
Whopper debt raising from Auckland Council.
Continuous Disclosure: Why are NZ companies flocking to the ASX?
What is happening on the markets this week.
Continuous Disclosure: Port of Tauranga, fund manager fees, bank dividends
The latest on the markets.
Continuous Disclosure: Could Metlifecare deal be start of something bigger?
Once Metlife is hoovered up, the Swedes could go even further.
How to protect your investments from coronavirus
Coronavirus proof your portfolio and prepare for more market volatility ahead.
Continuous Disclosure: How much the Kiwibank-BNZ deal could cost
A market listing would be lapped up by investors and KiwiSaver funds.
Continuous Disclosure: What made the naughty and nice list for investors in 2019
Experts share their best and worst moments of the year.
Continuous Disclosure: MET's mystery bidder, Moutter cashes in and Xero's $80 landmark
What's happening on the markets this week.
Stock Takes: SkyCity warned over debt blowout risk
SkyCity's credit rating could come under pressure if its debt ratios blow out.
Rich lister's buying spree
Interests associated with the Gough family have bought into a second fund manager.
Continuous Disclosure: Who's next on private equity shopping list?
Market news and opinion updated throughout the week.
Who could be next on private equity's shopping list?
Who could be next on the buy list for private equity?
NZ's dying life insurance industry
The life insurance industry is struggling to attract new buyers.
Fletcher shares low enough for a takeover?
Fletcher Building shares have fallen so low it could be a bargain price for a buyer.
Share market research to go Pokemon-style
An equity research firm is to use augmented reality to appeal to more millennials.
Stock Takes: Bank inquiry hits shareholders in the pocket
Our take on the markets this week....
Winners and losers, post-election
Investors are already picking winners and losers, post election.
Mainfreight breaks through $100m
Mainfreight's result stood out among the corporate earnings reports.